Annual Congress Vienna 2012

Saturday, 01.09.2012
Sunday, 02.09.2012
Monday, 03.09.2012
Tuesday, 04.09.2012
Wednesday, 05.09.2012

Citations should be made in the following way: Authors. Title. Eur Respir J 2012; 40: Suppl. 56, abstract number.



Pulmonary circulation: clinical aspects of PAH and associated PH

Thematic Poster Session
Chairs: L. Howard (London, United Kingdom), M. Johnson (Clydebank, United Kingdom), I. Lang (Vienna, Austria), D. Montani (Kremlin Bicêtre, France)
Analysis of BMPR2 mutations, and endothelin-1 and nitric oxide synthase genes polymorphisms in pulmonary arterial hypertension
D. Valverde, A. Baloira, G. Pousada, M. Núñez, C. Vilariño (Pontevedra, Vigo, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Evaluation of acute right ventricular failure in scleroderma and idiopathic pulmonary arterial hypertension
N. Chaisson, A. Campo, S. Mathai, P. Hassoun (Baltimore, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Non-invasive versus invasive heamodynamic evaluation in an heterogeneous pulmonary hypertension population: When echo goes in the cath-lab
M. D‘Alto, E. Romeo, P. Argiento, A. Correra, B. Sarubbi, M. Pignatiello, A. Caronna, N. Grimaldi, R. Calabrò, M.G. Russo (Naples, Italy)
Congress or journal article abstract
Congress or journal article abstract
Effect of targeted therapy on circulating endothelial progenitor cells in precapillary pulmonary hypertension
R. Del Pozo, J. Garcia, S. Pizarro, N. Coll, I. Blanco, Y. Torralba, V. Peinado, J. A. Barbera (Barcelona, Spain)
Congress or journal article abstract
Congress or journal article abstract
HbA1c in pulmonary arterial hypertension – A marker of prognostic relevance?
M. Belly, H. Tiede, O. Horst, G. Ardeschir, S. Werner, F. Reichenberger (Giessen, Germany; Graz, Austria)
Congress or journal article abstract
Congress or journal article abstract
Efficacy and safety of oral bosentan in patients with Down‘s syndrome and pulmonary arterial hypertension due to congenital heart disease
M. D‘Alto, E. Romeo, P. Argiento, A. Correra, B. Sarubbi, M. Pignatiello, A. Caronna, C.D. Vizza, R. Calabrò, M.G. Russo (Naples, Rome, Italy)
Congress or journal article abstract
Congress or journal article abstract
Assessment of left ventricular function in COPD
J. Mallik, K. Saha, S. Sarkar, A. Bannerjee (Kolkata, India)
Congress or journal article abstract
Congress or journal article abstract
Role of right ventricular ejection fraction by electrocardiogram- gated 320-slice CT in pulmonary hypertension
T. Sugiura, N. Tanabe, Y. Matsuura, A. Sekine, K. Tatsumi (Chiba, Japan)
Congress or journal article abstract
Congress or journal article abstract
Relevance of persistent foramen ovale in PAH patients on pulmonary vasoactive treatment
I. Mascher, H. Tiede, C. Tanislav, R. Voswinckel, H. A. Ghofrani, W. Seeger, F. Reichenberger (Giessen, Gauting, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Pulmonary arterial hypertension associated to HIV infection
J.M. Palmero, R. Pitti, L. Eiroa, P. Jimenez, L. Pérez, M. Miguelez, A.I. Velazquez, A. Pérez, A.I. Hernández, M. Figueira, J. Rodriguez, J.J. Batista (Santa Cruz de Tenerife, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
A. Micco, E. Carpentieri, G. Del Giudice, A. Russo, A. Romano, G. Beatrice, M. Del Donno (Benevento, Italy)
Congress or journal article abstract
Congress or journal article abstract
Efficacy of exercise training in congenital heart disease associated pulmonary hypertension
T. Becker-Gruenig, N. Ehlken, M. Gorenflo, A. Hager, M. Halank, H. Klose, M. Lichtblau, A. Meyer, F. Reichenberger, S. Sorichter, R. Speich, S. Ulrich, E. Gruenig (Munich, Dresden, Hamburg, Mönchengladbach, Giessen, Germany; Zurich, Switzerland)
Congress or journal article abstract
Congress or journal article abstract
The utility of brain natriuretic peptide in patients with stable chronic lung diseases
Y. Kida, H. Tomioka, R. Sekiya, S. Yamashita, T. Kaneda, C. Nishio, M. Kaneko, H. Fujii, K. Ishihara (Kobe, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Resolution of portopulmonary hypertension (POPH) following liver transplantation
M. Krowka, R. Cartin-Ceba, K. Swanson (Rochester, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Factors determining outcome in patients with heart failure and normal ejection fraction
C. Tufaro, J. Mascherbauer, B. Marzluf, T. Binder, I. Lang, D. Bonderman (Vienna, Austria)
Congress or journal article abstract
Congress or journal article abstract
Pulmonary hypertension frequency in patients with chronic obstructive pulmonary disease exposed to biomass or tobacco smoke
B. Sertogullarindan, H.A. Gumrukcuoglu, C. Sezgi, M.A. Akil (Van, Diyarbakir, Turkey)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
A study of suspected pulmonary embolism (PE) in pregnancy management and a survey of guideline awareness
I. Felton, K. Wimble, P. Murray (Chertsey, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
VO2 equations revised: Is the use of assumed oxygen consumption acceptable?
S. Desole, K. Dolp, C.M. Kähler (Innsbruck, Austria)
Congress or journal article abstract
Congress or journal article abstract
Impaired peripheral brachial endothelial function in IPAH and CTEPH without cardiovascular risk factors
C. Lensch, R. Kaiser, R. Bals, H. Wilkens (Homburg/Saar, Germany)
Congress or journal article abstract
Congress or journal article abstract